Drug resistance is estimated to affect about a third of individuals with epilepsy, but its
prevalence differs in relation to the epilepsy syndrome, the cause of epilepsy, and other …

Epilepsy is a chronic neurological disorder characterised by recurrent unprovoked seizures.
1 It affects an estimated 50 million people worldwide with no socio-demographic boundary …

Objective This study investigated early, real‐world outcomes with cenobamate (CNB) in a
large series of patients with highly drug‐resistant epilepsy within a Spanish Expanded …

Objective This study was undertaken to quantify epilepsy‐related costs of illness (COI) in
Germany and identify cost‐driving factors. Methods COI were calculated among adults with …

The vast majority of studies that process and analyze neural signals are conducted on cloud
computing resources, which is often necessary for the demanding requirements of deep …

Background and Objectives To examine the preferences and user experiences of people
with epilepsy and caregivers regarding automated wearable seizure detection devices …

For many years, disability-adjusted life-years have been a primary focus of the landmark
Global Burden of Disease studies [1]. Incorporating years of life lost and years of life lived …

Objective This study was undertaken to calculate epilepsy‐related direct, indirect, and total
costs in adult patients with active epilepsy (ongoing unprovoked seizures) in Germany and …

A substantial proportion of individuals with newly diagnosed epilepsy report prior seizures,
suggesting a missed opportunity for early epilepsy care and management. Consideration of …

Artificial intelligence (AI) and health sensory data-fusion hold the potential to automate many
laborious and time-consuming processes in hospitals or ambulatory settings, eg home …